FSD Pharma Inc C.HUGE

Alternate Symbol(s): HUGE

Healthcare Cannabis

FSD Pharma Inc. is a Canada-based biotechnology company. The Company operates through two segments: Biotechnology and Strategic Investments. Its Biotechnology segment is focused on furthering the research and development of the Company’s two primary drug candidates consisting of Lucid-MS and Lucid-PSYCH, as well as the development of UNBUZZD. The Company’s Strategic Investments segment is focused on generating returns and cashflow through the issuance of loans secured by residential or commercial real estate property. Lucid-PSYCH is a molecular compound identified for the potential treatment of mental health disorders. Lucid-MS is a molecular compound identified for the potential treatment of neurodegenerative disorders. UNBUZZD is a proprietary formulation of natural ingredients, vitamins, and minerals to help with liver and brain function for the purposes of potentially quickly relieving from the effects of alcohol consumption, such as inebriation, and restoring normal lifestyle.

CSE:HUGE - Post by User

FSD Pharma Inc > Lets get this back up , where are all the market makers

<< Previous

Bullboard Posts

Next >>

Comment by Walter333on Feb 04, 2022 10:30am

41 Views

Post# 34397338

RE:RE:Lets get this back up , where are all the market makers

Unfortunately I do not see David stopping whether he either refused or his options in pump expire or not, he's a former DJ and promotion is in his DNA. It is my belief that this individual enjoyed the high of being a part of something and promoting it,got wrapped up in the excitement,emotions and relationship that he has or thinks he has with AD. Have you disclosed that you were offered options in exchange for promoting this company David? https://www.google.com/url?sa=t&source=web&rct=j&url=https://webfiles.thecse.com/World_Class_Extractions_files_CSE_Form_11_-_Notice_of_Proposed_Stock_Option_-_April_9_2019.pdf%3FtXQzRXt.333qw7qsieU7wjequxRn6tn.%3D&ved=2ahUKEwi-29yyq-T1AhUPHzQIHSGXD_kQFnoECAMQAQ&usg=AOvVaw0gEpLLB1Oozd67BRRukMni [quoteMil_Man54]Were you wearing your cheerleader outfit and waving your pom poms as you typed that post Rosenberg....

DavidRosenberg wrote:

Here is what needs to happen

Yes, the stock price has been down since 2018.

They have 3 drugs one for inflammation called FSD PEA

One for Major Depressive Disorder which is categorized as a potential treatment for neuropsychiatric disease which uses psychoactive drug that Lakshmi Kotra and his team discovered it's not patented as of yet.

Lucid MS is patented. LUCID MS for multiple Sclerosis.

They have the facility up for sale, they haven't sold it as of yet hopefully that gets done one day.

Anthony Durkacz is only interim CEO they need to find someone solid with real biotech history to take over in the near future to grow the company even more.

Arbitration has to be dealt with for Raza Bokhari. The courts sided with FSD Pharma against Raza and sent it off to arbitration.

The future of FSD Pharma will be hard to restore unless they get all these things in order. Aside from most biotech Nasdaq indexes being down etc.

So let's see

Zeeshan has been averaging down , so has Anthony Durkacz.

Share Repurchase program is in affect which could reduce the float from 40,5M shares to 38.5M Shares

AD took over as CEO since 2021 July, so the pressure is on him to make sure shareholders are happy and stock price goes up.

The new website looks great.